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1 LONG-TERM SAFETY OF LAPAROSCOPY IN PATIENTS
WITH CIRRHOSIS
Cobb WS2, Reindollar RW1, Heniford BT2, Kercher KW2,
(1) Carolinas Center for Liver Diseases; (2) General Surgery,
Carolinas Medical Center, Charlotte, NC, USA
INTRODUCTION ANDAIM: The proven benefits of laparoscopy
may help to lessen the morbidity and mortality associated with
abdominal surgery in patients with cirrhosis. This study evaluates the
long-term safety and efficacy of laparoscopic procedures on con-
secutive patients with cirrhosis. PATIENTS AND METHODS:
Retrospective review of all patients with biopsy-proven cirrhosis
undergoing laparoscopic surgery at our institution between January
2000 and November 2004. RESULTS: Sixty-one patients (34 male,
29 female) (46, Child-Pugh class A; 14, Child-Pugh B; 1, Child-
Pugh C), underwent 64 laparoscopic procedures. These included
cholecystectomy (29), splenectomy (20), colectomy (4), diagnostic
laparoscopy (4), ventral hernia repair (2), adrenalectomy (1), Nissen
fundoplication (1), Heller myotomy (1), Roux-en-Y gastric bypass
(1), and radical nephrectomy (1). There were three conversions
(4.7%) to an open procedure due to adhesive disease. Mean opera-
tive time was 154 minutes. Estimated blood loss averaged 112 ml for
all procedures. Baseline coagulopathy was empirically corrected with
FFP and platelet transfusion in 20 (33%) patients. Only one patient
required PRBCs due to anemia. There were no acute bleeding
episodes. There was one re-admission for hepatic decompensation.
The mean LOS was 2.9 days. At a mean follow-up of 12.6 months,
overall morbidity was 18%. One cardiac death occurred at home,
5 weeks after discharge, and was unrelated to surgery. CONCLU-
SION: While technically challenging, basic as well as complex
laparoscopic procedures can be safely performed in patients with
mild to moderate cirrhosis. When carried out with judicious
management of coagulopathy, low perioperative morbidity rates and
rapid convalescence can be achieved in this high-risk group.
2 COMPARISON OF VENTRAL HERNIA REPAIR IN
CIRRHOTIC AND NON-CIRRHOTIC PATIENTS: OUTCOMES
AND COST
Harrell AG1, Novitsky Y1, Lincourt A2, Rosen M1, Kercher K1,
Heniford BT1, (1) Surgery, Carolinas Medical Center; (2) Dickson
Institute for Health Studies, Carolinas Medical Center,
Charlotte, USA
INTRODUCTION AND AIM: Evidence suggests that ventral
hernia repair (VHR) in patients with cirrhosis has an increased
morbidity when compared to non-cirrhotic patients. The difference
in outcome and costs was investigated. PATIENTS AND METH-
ODS: The 2002 Nationwide Inpatient Sample (NIS) (995 nation-
wide hospitals) was queried. Inpatient VHR data were separated into
cirrhotic and non-cirrhotic patients. Demographic information,
emergent/elective repair, length of stay (LOS), charges, complica-
tions and death rates were compared. RESULTS: In the 2002 NIS,
38,549 VHR were documented. Of those, 760 were performed on
cirrhotic patients. The average LOS (10 vs 6 days, p50.0001), the
total charges ($53,917 vs $27,676, p50.0001), complications (23%
vs 20%, p50.03), and the death rates (7.8% vs 1.5%, p50.0001)
were all statistically different between the patients with and without
cirrhosis. In emergent operations, LOS (11 vs 8.6 days, p=0.0001)
and mortality (11.6% vs 3.2%, p=0.0001) were significantly greater
in cirrhotics. In elective VHR, cirrhotics had significantly greater
LOS (7.9 vs 4.6 days, p=0.0001) and death rates (3.3% vs 0.6%,
p=0.0001). Rates of complications were not statistically different.
Cirrhotic patients undergoing emergent VHR had a 3.5 times higher
mortality than cirrhotics undergoing elective VHR (p=0.0001).
CONCLUSION: The impact of cirrhosis on VHR outcomes and
cost is significant. Cirrhotic patients had a longer hospital stay and
increased total charges and mortality when compared to patients
without cirrhosis. Cirrhotic patients undergoing an elective instead of
an emergent VHR have a dramatically reduced mortality rate. VHR
in any patient with cirrhosis should be approached cautiously and in
the elective setting if possible.
3 REMOTE RESULTS OF MINI-INVASIVE
INTERVENTIONS IN DECOMPENSATED LIVER CIRRHOSIS
Chooklin S, Perejaslov A, Department of Surgery, Medical
University, Lviv, Ukraine
INTRODUCTION AND AIM: The presence of combined
complications in liver cirrhosis patients determines the insufficiency
of only one intervention. PATIENTS AND METHODS: The
remote results of consecutively applying of mini-invasive interven-
tions (embolization of a.lienalis and a.gastrica sinistra, endoscopic
sclerotherapy of esophageal varices, peritoneovenous shunting) in 50
liver cirrhosis patients (Child-Pugh B, 27; C, 23) were analyzed. All
patientshadesophageal varicesof grade III andascites, and39of them
had secondary hypersplenism. RESULTS: Sufficient results were
achieved in 40 patients. The complete obliteration of esophageal
varices was achieved in 38 patients after applying a combination of
arterial embolization and prolonged endoscopic sclerotherapy. The
recurrence of bleeding was not noted in this group of patients. The
disappearance of clinical manifestation of secondary hyperslenism
with preserved moderate cytopenia of peripheral blood was noted in
all patients. Ascites had fully disappeared or was controlled by con-
ventional therapy without necessity for paracentesis in 40 patients.
Significant improvement of indices of liver functionwas noted in 53%
of patients, in 28% the indices were stabile, and in 17% they became
worse. The unsatisfactory results in 10 patients were determined by
the occurrence of variceal bleeding (3 patients) and ascites progres-
sion (7 patients). CONCLUSION: The application of the given
management in high-risk patients is the perspective and optimal.
4 PORTAL BILIOPATHY IN A CIRRHOTIC PATIENT
Palep RJ1, Shah S1, Desai D2, (1) Gastrointestinal Surgery;
(2) Gastroenterology, PD Hinduja Hospital, Mumbai, India
INTRODUCTION AND AIM: Portal biliopathy is obstructive
jaundice in a case of portal hypertension due to collaterals and is well
described in patients with portal cavernomas. We report one case of
portal biliopathy in a cirrhotic patient with no cavernoma.
PATIENTS AND METHODS: A 21-year-old male patient
presented 6 years after diagnosis of portal hypertension and endo-
scopic treatment of varices with obstructive jaundice. (Childs A with
total bilirubin 9 mg, direct bilirubin 6.5 mg; hepatitis B positive).
Ultrasonography and MRCP showed narrowing at the common
hepatic duct and intrahepatic biliary radical dilatation. USGDoppler
revealed a patent portal vein and collaterals at hilum. Endoscopic
stenting reduced the jaundice. RESULTS: The patient had two
attacks of cholangitis and underwent a change of stent. He then
developed blockage of the stent due to stones. Hence a decision for
bilioenteric bypass was taken. Choledochoscopy done on table
showed normal mucosa and normal cytology on brushings. The
patient is well 18months after successful hepaticodochojejunostomy.
CONCLUSION: Portal biliopathy in a cirrhotic is rare and can be
successfully treated by bilioenteric bypass.
5 THE ROLEOF THECD95 APOPTOSIS SYSTEM IN VIRUS
ELIMINATION OF HBV
Koch AF1, Dax A1, Schirmacher P2, Stremmel W1, Krammer P3,
Protzer U4, Mu¨ller M1, (1) Department of Internal Medicine IV,
University ofHeidelberg; (2)Department of Pathology,University of
Heidelberg; (3) Tumor Immunology Program, DKFZ, Heidelberg,
Germany; (4) Center ofMolecularMedicine, University of Cologne,
Cologne, Germany
INTRODUCTIONANDAIM: Persistent infection with hepatitis B
virus (HBV) represents a major health problemwith over 350million
patients worldwide at risk of developing liver cirrhosis or hepato-
cellular carcinoma.We investigated the role of apoptotic pathways in
HBV elimination and persistence. PATIENTS AND METHODS:
p53 and expression plasmids of the HBV proteins were transferred
into Hep3B Cells (p53-/-) using adenoviral vectors. The apoptotic
pathways were investigated by FACS analysis (staining for specific
apoptosis death receptors, mitochondrial membrane potential) and
luciferase reporter assays. CD95 deficient (lpr) and CD95 positive
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(wt) CH57BL6-mice were infected with HBV using an adenoviral
genome transfer. Serological parameters (ALT,HBV-DNAand anti-
HBS) were investigated over 28 days post infection. The livers of the
mice were investigated by immunohistochemistry. RESULTS:
In vitro: Co-transfection of HBV and wt p53 leads to a synergistic
transactivation of the CD95 and the Bax gene. Using HBV knockout
constructs we identified HBx as responsible for p53 cooperation.
In vivo: Histological investigation of the livers showed infiltration of
lymphocytes in all mice, but only CD95-positive mice had altered
ALT levels as a sign of liver damage. In contrast to CD95-deficient
mice the wt mice were able to control the HBV infection on day 14.
In CD95-deficient mice no virus elimination was detected.
CONCLUSION: Our in vivo data demonstrate that an intact CD95
apoptosis pathway is essential for virus elimination in HBV infection.
HBV proteins alone do not lead to apoptosis induction, but together
with wt p53 apoptosis genes like CD95 and Bax are activated to
provide the precondition for virus elimination.
6 LIVER HYTADID DISEASE AND RADIOFREQUENCY
ABLATION
Zacharoulis D2, Tzovaras G1, Tepetes K1, Athanasiou E1,
Hatzitheophilou K1, (1) Surgery, University of Thessaly;
(2) Department of Surgery, University of Thessaly, Larissa, Greece
INTRODUCTION AND AIM: Several techniques have been
described in liver hydatid disease surgery, with most well known
being deroofing and omentoplasty, partial cystectomy and pericys-
tectomy. However, the procedure can be technically demanding.
Major complications include haemmorhage, bile leak, abscess
formation and reccurence of the hytadid cyst. PATIENTS AND
METHODS: We present a technical modification of open peri-
cystectomy for liver hydatid disease using radofrequency ablation
(RFA). 16 patients with liver echinococcosis underwent peri-
cystectomy after evacuation of the cyst using RFA.The results have
been compared with a historical group of patients. RESULTS: The
operative time for the RFA group was median 120 min vs 80
(p50.05). The blood loss was minimal for the RFA group vs 200
(100–700) for the non-RFA group (p50.01).The hospital stay was 6
days vs 10. One patient presented with biliary leak immediately
postoperatively vs 9 patients from the non-RFA group. CONCLU-
SION: RFA can be used with safety in liver hytadid disease. It can be
slower but the blood loss is much less than in other techniques. It is
associated with less morbidity and shorter length of stay.
7 PERIPHERAL BLOOD DENDRITIC CELL SUBSETS AND
SERUM INTERLEUKIN-12 LEVELS IN PATIENTS WITH
CHRONIC HEPATITIS C VIRUS INFECTION: RELATION TO
DISEASE ACTIVITY
El Aggan HA2, Farahat N1, Mohamed F2, Emam E1, Gaballah E2,
(1) Department of Clinical Pathology; (2) Department of Medicine
(Hepatobiliary Unit), Faculty of Medicine, University of
Alexandria, Egypt
INTRODUCTION AND AIM: Hepatitis C virus (HCV)-specific
T-cell immune responses appear to influence the outcome of infec-
tion and require activation by dendritic cells (DCs). The present
workwas designed to study theDC subsets in peripheral blood and to
assess the serum levels of interleukin-12 (IL-12) in patients with
chronic hepatitis C in relation to disease activity. PATIENTS AND
METHODS: 28 patients with chronic hepatitis C (15 with elevated
serum levels of alanine aminotransferase (ALT) and 13 with persis-
tently normal ALT levels) and 12 healthy subjects were included in
the study. Themyeloid and lymphoidDC subsets in peripheral blood
were detected using 3-color flow cytometry and were differentiated
by the expression of CD11c or CD123 on the cell surface, respec-
tively. Determination of IL-12p70 heterodimer in serum was
performed using enzyme-linked immunosorbent assay. RESULTS:
The percentages of peripheral blood DC subsets (CD11c+ and
CD123+), the CD11c+ DC/CD123+ DC ratio and the serum
IL-12 levels were significantly lower in chronic hepatitis C patients
than in healthy subjects and in patients with elevated ALT than in
those with normal ALT (p50.05). The reduction in circulating DC
subsets and serum IL-12 levels showed negative correlations with
serum levels of ALT and the histopathological grading and staging
scores (p50.05) but not with serum HCV RNA levels (p40.05).
CONCLUSION: The deficiencies in circulating DC subsets and
IL-12 production may play a key role in the progression of liver
disease in chronic HCV infection and may provide a potential new
goal for HCV immunotherapy.
8 AUDIT OF PYOGENIC LIVER ABSCESS IN A DISTRICT
HOSPITAL IN THE UK
Satyadas T, Habbab Y, Rae DM, SinclairMT, EasternHepatobilary
Pancreatic Unit, Ipswich Hospital, Ipswich Suffolk, UK
INTRODUCTION AND AIM: Pyogenic liver abscess remains a
major therapeutic challenge. Even though the incidence of liver
abscess remained relatively stable, there has been a change in
distribution of the causative factors that lead to liver abscess. Our
aim was to review our management of pyogenic liver abscess.
PATIENTS AND METHODS: Retrospective analysis of the case
notes of 19 consecutive patients, who were admitted to our hospital
with pyogenic liver abscess was done. Cases were identified by the
particular clinical code for pyogenic liver abscess. RESULTS: There
were 19 cases of pyogenic liver abscess between January 1997 and
October 2004. Of the 19 patients, 13 were men and 6 women. Age
ranged from 23 to 80 years. All patients were treated with image-
guided (US or CT) percutaneous aspiration or drainage and anti-
biotics. Portal vein pylephlebitis secondary to colonic diverticulitis
was the cause in 6 of 19 patients (31.6%). 5 were secondary to biliary
tract disease (26.3%), 3 due to systemic bacteremia (15.8%), and in
another 5 no cause could be found (26.3%). Only the right lobe was
involved in 11 patients (57.9%), left lobe in 3 and both lobes in 5
cases. Solitary abscess was found in 10 cases and it wasmultiple in the
other 9 patients. Cultures showed coliforms as the most common
offending organism, found in 8 patients (42.1%). Streptococcus milleri
was found in 4, bacteroids in 3 and no organism was cultured in 6
patients. There was no mortality and all patients made a complete
recovery. The mean hospital stay was 21.5 days (range 6–51 days).
All patients had repeat imaging before discharge and on follow-up.
CONCLUSION: Early diagnosis and prompt image-guided percu-
taneous aspiration or drainage and treatment with antibiotics
provides good results in the management of pyogenic liver abscess.
Our study showed that it is not always possible to find the aetiology or
the organism causing the abscess. We recommend that all patients
with pyogenic liver abscess should have thorough investigation of the
biliary tract and colon to identify the cause and to provide optimum
care to the patient.
9 SURGICAL TREATMENT OF HEPATIC HYDATID
DISEASE: ANALYSIS OF 276 PATIENTS
KucukC, Artis T, AkyildizH, Akcan A, Sozuer E, Yilmaz Z, General
Surgery, Erciyes University School of Medicine, Kayseri, Turkey
INTRODUCTION AND AIM: Hepatic hydatid disease is still an
endemic health problem in our country as in some other areas of the
world. Surgical therapy is the most effective treatment method
available today. In this sudy we aimed to review our experience of 276
patients with hepatic hydatid disease. PATIENTS AND METH-
ODS: Patients who had undergone surgical therapy with diagnosis
of hepatic hydatid disease were retrospectively reviewed during
the 15-year period between January 1990 and November 2004 at
the Department of General Surgery, Erciyes University Medical
School, Kayseri, Turkey. Overall 276 patients with hepatic hydatid
disease were included the study. Patients’ demographic character-
istics, symptoms, diagnostic tools, surgical treatment methods and
complications were analyzed. RESULTS: Of 276 patients, 152
(55%) were male and 124 (45%) were female. Mean age was 42.1
(18–77). The most common complaints were right upper quadrant
and epigastric pain (38.4%). At the physical examination hepato-
megaly was the most common finding (36.9%). Preoperative
abdominal ultrasound (USG) and computed tomography (CT) were
done in 265 and 123 patients, respectively. USG and CT were both
used together in 112 patients (36.9%). Seventeen patients (6.4%)
with USG and 3 (2.4%) with CT showed miscorrelation with the
surgical exploratory findings. In 23 patients (8.3%) cyst was ruptured
and perforated into the abdominal cavity and also in 45 patients
(16.3%) a fistula between cyst cavity and biliary tract was found.
Cystodrainage with partial cystectomy was the most commonly
performed surgical procedure in 196 (71%) patients. Patient with
biliary tract opening cysts were managed with primary repair and
T-tube placement (n=40, 14.5%) or choledochoduodenostomy
(n=5.2%). No perioperative mortality was observed and post-
operative morbidity rate was 7.2% (n=20). Biliary fistula was
the most common complication (3.2%). Six patients (2.1%) had
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intra-abdominal abscess. CONCLUSION: Although the improve-
ment in conventional treatment modalities, surgical therapy is still
the main treatment option for hepatic hydatid disease. Even with
complicated cases it can be managed with low morbidity and
mortality.
10 SURGICAL TREATMENT OF LIVER ALVEOLAR
ECHINOCOCCOSIS
Polanski JA2, PaulM1, Biacek P2, Biejat Z2, PolanskaM2, Nitkowski
P2, Szubert A2, Stefaniak J1, (1) Department of Infectious Diseases,
Medical University of Pozna, Pozna, Poland; (2) 2nd Department of
Surgery, Medical University of Warsaw, Warsaw, Poland
INTRODUCTION AND AIM: Echinococcus miltilocularis invades
the human body and spreads in our organism like a cancer. The
primary site of invasion is the liver. Surgery is an integral part of
treatment for a patients with advanced disease with extensive liver
involvement. We present our limited experience and results of the
treatment of alveolar echinococcosis. PATIENTS AND METH-
ODS: During the period between 1995 and 2004, 6 patients
underwent extensive hepatic resections for a parasitic tumor of the
liver due to infection by Echinococcus multilocularis (4 women and 2
men; mean age 42.3). Diagnosis was confirmed by visualization with
ultrasound andCT scan and serology with ELISA test (Em, Em2+).
All of them were in advanced stage of the disease (IIIa, IIIb, IV –
PNM classification) and received medical treatment preoperatively.
RESULTS: One patient died during the postoperative period, and
another died 3 months after surgery, both due to liver insufficiency.
Four patients are alive 12–108 months after extensive liver resection
and onmedical treatment without evidence of progress of the disease.
CONCLUSION: Extensive hepatic resection with chemotherapy
creates a chance for long-term survival in advanced stages of alveolar
echinococcosis.
11 CLINICAL PRESENTATIONS AND SURGICAL
MANAGEMENT OF LIVER HYDATIDOSIS: OUR 20-YEAR
EXPERIENCE
Avgerinos ED, Pavlakis E, Stathoulopoulos A,Manoukas E, Skarpas
G, Tsatsoulis P, 2nd Surgical Department, General Hospital
Aslepeion Voulas, Athens, Greece
INTRODUCTION AND AIM: Hydatidosis-echinococcosis of the
liver is a very old and still existing, although declining problem in
Greece. We review our 20 years’ experience, report the various
clinical presentations of the disease and evaluate the clinical outcome
of the surgical procedures performed. PATIENTS AND METH-
ODS: We conducted a retrospective analysis of the past 20 years’
medical records. 35 patients (males 33%, females 67%, mean age 58
years) were treated surgically. RESULTS: The presenting symptoms
or findings leading to the diagnosis of liver echinococcosis were
jaundice (6 cases, 18%), abdominal pain (5 cases, 15%), gastro-
intestinal discomfort of the upper abdomen (nausea, vomiting,
distention, anorexia, etc.) (2 cases, 6%), acute pancreatitis (1 case,
3%), portal hypertension (1 case, 3%) and one strangulated umbil-
ical hernia (1 case, 3%). The rest of the cases were diagnosed inci-
dentally (19 cases, 58%). External drainage was performed in 20
cases (57%) and cystectomy in 14 cases (40%), while omentoplasty
was performed on the residual cavity. The mean hospital stay was
16.8 days postoperatively. Morbidity and mortality were 38.7% and
3%, respectively. The recurrence rate averaged 3%. CONCLU-
SION: A high index of suspicion is recommended when variable
clinical manifestations of the upper abdomen are present. External
drainage and cystectomy should be the standard surgical procedure
and meet all criteria of surgical treatment for hydatid disease: entire
elimination of the parasite, no intraoperative spillage, and saving
healthy tissue. Resectional procedures were considered too radical
for a benign disease. Pericystectomy should be used for peripherally
located liver cysts that are surrounded by parenchyma only partially.
Appropriate randomized controlled studies are needed to establish
the definite surgical management of liver hydatidosis.
12 PROBIOTIC PROPHYLAXIS IN SURGICAL PATIENTS:
A META-ANALYSIS
Besselink MGH, Timmerman H, Akkermans L, Gooszen H,
Surgery, University Medical Center Utrecht, Utrecht, The
Netherlands
INTRODUCTION AND AIM: Several randomised controlled
trials (RCTs) have been performed in order to demonstrate a
prophylactic effect of probiotics on postoperative infectious com-
plications in surgical patients. PATIENTS AND METHODS:
Through Pubmed search six RCTs were identified. A meta-analysis
was performed. RESULTS: No absolute risk reduction was found
(ARR 2%, 95% CI –10 to 5.1). However, in two RCTs in acute
pancreatitis (n=45 patients) and liver transplantation (n=63
patients) enteral probiotics did reduce the number of infectious
complications (ARR 23%, 95% CI 8–35). Both trials used the
probiotic strain Lactobacillus plantarum 299v, in combination with
fibre-enriched feeding administered via a jejunal feeding tube. Four
other RCTs studying general ‘gastrointestinal-HPB’ surgery patients
(total n=419) failed to show a prophylactic effect. Lactobacillus
plantarum 299v was used in two of these trials. In between trials there
was a wide variation in the relative number (percentage) of infections
though (median 28%, range 5–73%). CONCLUSION: Significant
reduction of infectious complications by probiotics was shown in liver
transplant and acute pancreatitis but not in general ‘gastrointestinal-
HPB’ surgery patients. Themajor differencemay be that infections in
the first two categories are due to increased proximal small bowel
permeability, whereas in the third category pathogenesis differs
between subgroups. Also methods and timing of administration
differed between trials. In all six trials, subgroup analysis is not
possible due to the small number of patients studied. To determine
an effect of (perioperative) probiotic prophylaxis on valid clinical
endpoints much larger double-blind, placebo-controlled RCTs are
warranted.
13 AUDIT OF PYOGENIC LIVER ABSCESS
Hariraj R2, Satyadas T1, (1) Surgery, Queen Elizabeth Hospital;
(2) Queen Elizabeth Hospital, Medicine, Kings Lynn, UK
INTRODUCTION AND AIM: Pyogenic liver abscess is not an
uncommon reason for hospital admission. A high index of suspicion
is necessary for early diagnosis and prompt treatment. This audit
aimed to study several aspects of the presentation and clinical
management of pyogenic liver abscess PATIENTS AND METH-
ODS: We retrospectively analysed all admissions under the clinical
coding for pyogenic liver abscess. There were 16 cases between 1996
and 2003. Several aspects of their admission and management were
studied. RESULTS: 38% were females and 62% were males. Age
range was 71–80 years. 38% were managed by surgeons and 62%
by physicians. Presenting complaints were variable and included
abdominal pain in 37.5%, jaundice in 6.25% and fever in 31.25%
Associated risks were recent appendicitis, colonic obstruction, pelvic
abscess and recent laparoscopic cholecystectomy. All the patients
underwent both ultrasound and CT scans of the abdomen. 62.5%
had raised alanine transferase, 37.5% raised alkaline phosphatase,
31% raised total bilirubin and 25%had raised alanine transferase and
alkaline phosphatase. Blood culture was positive in five while abscess
cavity culture was positive in 10 patients. Streptococcus milleri was
grown in seven patients. The right lobe was affected in six; the left
lobe in three and seven cases had bilobar affection. There was
complete recovery in 11, recurrence in 2, and 3 deaths, although 2
of them died from other causes. Colonic investigations revealed
malignancy in one and diverticulosis in three. CONCLUSION:
Pyogenic liver abscess has protean manifestations. An offending
organism can almost always be cultured. Abscess aspiration for
culture should always be attempted. Prompt treatment with anti-
biotics as dictated by culture results, should ensure recovery. Asso-
ciated risk factors, in particular, recent abdominal surgery, should be
sought after. All patients should undergo colonic investigations to
identify an underlying colonic source for the abscess.
14 SURGERY IN CYSTIC ECHINOCOCCOSIS (CE): WHAT
IS EVIDENCE-BASED?
Buttenschoen K, Henne-Bruns D, Department of General Surgery,
University of Ulm, Ulm, Germany
INTRODUCTION AND AIM: Surgery, chemotherapy and inter-
ventional procedures are therapeutic options for CE. Surgery cures
patients if the parasite is removed entirely. However, technical
procedures are diverse. PATIENTS AND METHODS: Literature
review and meta-analysis of current strategies and relevant issues:
diagnosis, indication for conservative and surgical treatment,
procedures, scolicidals, morbidity, mortality, recurrence, perio-
perative medication, standards. RESULTS: Any operation aims at
complete elimination of the parasite. Liver resection and pericys-
tectomy remove cysts with a safe distance. However, most surgeons
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consider them as too radical for a benign disease and prefer conser-
vative methods which remove the parasite and keep the pericyst. The
remaining cyst cavity is preferably closed by omentoplasty. Scolici-
dals and benzimidazoles are supportive measures. Meta-analysis of
lethality (1.2%/2%), morbidity (11.7%/23%), and recurrence (2%/
10.4%) ranks radical procedures always above conservative ones.
However, scientific evidence of available publications is limited. This
is because there are no prospective comparisons of radical versus
conservative procedures; the natural course of CE is ignored; no
stage-dependent decision making; limited numbers of patients are
examined; variation within conservative and radical procedures;
evaluation of scolicidal effects is lacking; arbitrary administration of
benzimidazoles; recurrence and persisting infection are not differ-
entiated; and others. Despite substantial uncertainty the literature
reflects a trend of the treatment as follows. CONCLUSION:
Cystectomy and omentoplasty should be the procedure of choice
because they are safe, simple, effective, and meet all criteria of CE
surgery: Entire parasite elimination, no spillage due to Aaron’s cone,
saving healthy tissue. Pericystectomy is indicated for cysts only
partially coated by parenchyma. Ultrasonography classifies parasitic
lesions conducting future therapy.
15 LAPAROSCOPIC SPLENECTOMY REVERSES
THROMBOCYTOPENIA IN PATIENTS WITH HEPATITIS C
CIRRHOSIS AND PORTAL HYPERTENSION
CobbWS3, Carbonell A1, Reindollar R2, Heniford BT3, Kercher K3,
(1) General Surgery, Virginia Commonwealth University Medical
Center, Virginia, USA; (2) Carolinas Center for Liver Diseases;
(3)General Surgery, CarolinasMedical Center, Charlotte, NC,USA
INTRODUCTION AND AIM: Thrombocytopenia commonly
prohibits the initiation or leads to the discontinuation of pegylated-
interferon plus ribavirin therapy that is potentially curative in patients
with chronic hepatitis C. We sought to determine the safety and
efficacy of laparoscopic splenectomy (LS) in correcting the throm-
bocytopenia, thus allowing resumption of interferon therapy.
PATIENTS AND METHODS: Data were collected prospectively
from 9/2000 to 11/2004 on patients who underwent LS for throm-
bocytopenia associated with interferon therapy and/or hepatitis C
cirrhosis with portal hypertension. RESULTS: Seventeen patients
(11 male/6 female) underwent LS, with a mean age of 47 (range, 27–
62), mean BMI of 28 kg/m2 (range, 21–44), Child-Pugh class A (14)
or class B (3), and a mean MELD score of 9.3 (range, 6–15). Mean
operative time was 175 min (range, 70–245), and blood loss aver-
aged 127 ml (range, 10–600). Twelve patients received prophylactic
transfusions, 11 platelets and one PRBC. Splenic weight averaged
1044 g (range, 245–1650). Average length of stay was 3.1 days
(range, 1–6). There were 4 patients with postoperative complica-
tions: trocar-site cellulitis (3) and self-limited atrial fibrillation (1).
Follow-up averaged 16.8 months. Postoperatively, mean MELD
score was 8.0 (range, 6–11). Platelet counts improved from a preo-
perative mean of 53,800/uL to 359,800/uL postoperatively and
remained above 100 K during subsequent pegylated-interferon
therapy. Currently, 6 patients have completed 48 weeks of pegylated-
interferon with undetectable (526 c/ml) viral counts at least 6
months post-treatment. CONCLUSION: LS is safe in the setting of
portal hypertension and thrombocytopenia associated with chronic
HCV infection. It can be performed with minimal blood loss and
perioperative morbidity. LS appears to effectively reverse thrombo-
cytopenia and may allow these patients to safely resume interferon
therapy.
16 LAPAROSCOPIC INCISIONAL HERNIA REPAIR IN
CIRRHOTIC PATIENTS
Belli G, D’Agostino A, Fantini C, Cioffi L, Belli A, Langella S,
S. Maria di Loreto Nuovo Hospital, Department of General and
HBP Surgery, Naples, Italy
INTRODUCTION AND AIM: In cirrhotic patients traditional
approaches to incisional hernias (IH) – particularly in cases with
large fascial defects – are plagued by a significant recurrence rate as
well as frequent wound infections. The laparoscopic repair of inci-
sional hernias was designed to offer a minimally invasive and tension-
free technique that yields less morbidity and fewer recurrences than
the standard open repair. In cirrhotic patients there are three reason
for this benefit of laparoscopy. First, preservation of the abdominal
wall avoids interruption of large collateral veins. Second, non-
exposure of viscera restricts decreases electrolytic and protein
losses, and improves absorption of ascites. Finally, the laparoscopic
approach was associated with a lower perioperative blood loss
(smaller abdominal incision). PATIENTS AND METHODS: A
retrospective review was performed for 37 consecutive patients with
ventral hernias who underwent laparoscopic repair at our institutions
(Department of General and Hepato-Bilio-Pancreatic Surgery)
between September 2002 and October 2004. Of those 14 have
chronic hepatitis or cirrhosis related to hepatitis C-B virus. All cir-
rhotic patients are in class A of Child Pugh classification. In 5
cirrhotic patients esophagogastroduodenoscopies showed evidence
of initial esophageal varices (grade F1). RESULTS: There were no
conversions to open operation. Themean size of the defects was large
at 87 cm2 (range 1–480). Incarceration was present in 2 patients, and
multiple (Swiss-cheese) defects in 1. In all cases, the mesh (average,
287 cm2 was secured with transabdominal sutures andmetal tacks or
staples leaving the sac in situ. Operative time and estimated blood loss
averaged 88 min (range 18–270) and 30 ml (range 10–150). Length
of stay averaged 2.6 days (range 0–6). There were 11 minor
complications: seroma lasting44 weeks (5), postoperative ileus (2),
suture site pain 42 weeks (2), urinary retention (1), and skin
breakdown (1).With an average follow-up of 8months (range 3–24),
there have not have been recurrences. CONCLUSION: Laparo-
scopic IH repair is technically feasible and safe in cirrhotic patients
with fascial defects. This operation decreases postoperative pain,
hastens the recovery period, and reduces postoperative morbidity
and recurrence.
17 IMPROVEMENT IN NONALCOHOLIC FATTY LIVER
DISEASE (NAFLD) WITH SURGICAL WEIGHT LOSS
Velcu LM, Mattar S, Rabinovitz M, Qureshi F, Collins J, Sacks B,
Lane B, Yenumula P, Schauer P, Surgery, University of Pittsburgh,
Pittsburgh, Pennsylvania, USA
INTRODUCTION AND AIM: The epidemic rise in incidence of
morbid obesity has seen a concurrent rise in NAFLD and, in asso-
ciation, the metabolic syndrome. The effect of surgical weight loss on
NAFLD is uncertain. The aim of this study was to assess the effect of
surgically induced weight loss on NAFLD. PATIENTS AND
METHODS: An analysis of patients who had serial needle liver
biopsies in conjunction with surgical therapy for morbid obesity was
performed. Demographic and outcome data were collected and
evaluated. Included in the analysis were laboratory markers of the
metabolic syndrome (hypertension, diabetes mellitus, hyperlipide-
mia and fatty liver disease). Liver biopsies were scored for NAFLD
grades (0 and stages 0–4). Statistical analysis was performed using
Sigmastat software. RESULTS: There were 62 patients, 72%
female, mean age of 47+9 years and initial BMI of 56.5+10.8. 44
patients (71%) met criteria for the metabolic syndrome. Repeat
biopsies were taken at 12+3.5 months after the initial procedure.
The mean BMI at the time of the second liver biopsy (12+3.5
months postoperatively) was 39.8+10.5, and 35 (80%) patients had
resolution of metabolic syndrome. There was a significant improve-
ment in grade (only 5 patients scored 2 or higher at the second biopsy
compared with 45 at the first biopsy, p50.0001) and stage (11
patients scored 2 or higher at the second biopsy compared with 27
patients at the first biopsy). CONCLUSION: Surgically induced
weight loss results in significant improvement of the histological
grading and staging of NAFLD and of the metabolic syndrome.
18 NEW APPROACH TO IMPROVED MODEL OF
CIRRHOTIC LIVER INDUCED BY CARBON
TETRACHLORIDE (CCL4)
Quadrelli L2, Secchi MA1, Consagra MF2, Rossi L3, Peralta E2,
Muniagurria C2, Gabriele M2, Figallo G2, (1) Pathology, University
Institute IUNIR; (2) Basic and Experimental Surgery, University
Institute IUNIR; (3) Laboratory, University Institute IUNIR,
Rosario, Argentina
INTRODUCTION AND AIM: Many models of carbon tetra-
chloride (CCL4)-induced liver cirrhosis in the rats have been
described. We had some success in different series (British Journal of
Surgery 1998; 85 Suppl 2: 111). In 2004 we tried a new approach to
this model selecting rats with less body weight. PATIENTS AND
METHODS: 248 Wistar male rats (E) were used in many series
between 1988 and 2004 and those which survived the procedure
were divided into two groups: Group 1 (n=248) to induce cirrhosis
and Group 2 (n=24) as control. The 2004 series included only rats
under 200 g of body weight (n=12). The intoxicationmethod was as
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follows: increasing doses of CCL4 by intragastric route according to
body weight changes and associated with subcutaneous doses. The
presence of ascites, serum level of ASAT, albuminemia, bilirrubi-
nemia and cholinesterase were recorded. Histological examination of
a liver sample was recorded in all animals. RESULTS: 112 rats
survived the procedure (45%); at week 10, 66 of them (60%) had
serological and histological evidence of liver cirrhosis with significant
differences compared to the control group. One group of 12 rats
remained under observation until 7 months post-intoxication,
showing evidence of delayed cirrhosis. CONCLUSION: Our model
is a simplified and improved method for inducing cirrhosisis that is
easy (16 doses), rapid (9 weeks), efficient (60%) and stable after 7
months in surviving rats. We think this is an appropriate method
when research involving cirrhotic rats demands longer periods of
time.
19 MICROBE PROLIFERATION IN SMALL INTESTINE IN
PATIENTS WITH HEPATIC CIRRHOSIS
Gubergrits NB, Linevsky Y, Lukashevich G, Chair of the Internal
Diseases No 1, Donetsk State Medical University, Donetsk, Ukraine
INTRODUCTION AND AIM: The profile of small intestine
microflora in patients with hepatic cirrhosis has not yet been
completely investigated, but intestinal dysbiosis could play an
important role in the development of hepatic hyperazotemia and
encephalopathy. This study aimed to study the composition of
intestinal flora in hepatic cirrhosis. PATIENTS ANDMETHODS:
Jejunal intubationwas conducted in 32 patients with hepatic cirrhosis
of viral etiology (group I) and that of 10 non-patients as control
(group II). Inoculation of medium by secretion from the proximal
part of jejunum and further pure culture determination, identifica-
tion of microorganisms and calculation of microbic bodies in 1 ml of
chyme was done. RESULTS: The number of species and quantity of
microbes in jejunal secretion were increased in group I. Yeast fungus,
yeast-like fungus, staphylococci, streptococci, diplostreptococci,
Escherichia coli and Proteus were revealed in those same patients.
Chronic jejenitis was discovered in biopsy of mucous membrane of
the small intestine which was done simultaneously with jejunal
intubation in 27 patients of group I. CONCLUSION: Therefore,
dysbiotical and morphological changes of small intestine in patients
with hepatic cirrhosis play an important role in development of
clinical manifestations of disease such as meteorism, difficult
evacuation of bowels, coprogramme pathology and others. This
determines expediency of therapy of the above-mentioned pathology
in case of hepatic cirrhosis of viral etiology.
20 RESULTS OF THE MODIFIED SUGIURA PROCEDURE
IN THE TREATMENT OF ESOPHAGEAL VARICEAL
BLEEDING FAILED IN NON-OPERATIVE THERAPY
Orug T, Bostancy` B, O¨zer I, Ozogul Y, Savky´ly´oglu M, Atalay F,
Akoglu M, Gastrointestinal Surgery, Tu¨rkiye Yu¨ksek Ihtisas
Teaching and Research Hospital, Ankara, Turkey
INTRODUCTION AND AIM: Devascularization procedure is one
of the alternative treatment modalities for those who have failed to
respond to endoscopic sclerotherapy, band ligation and TIPS for
control of acute variceal bleeding. In this study we evaluated the
results of a modified Sugiura procedure in patients who had different
types of portal hypertension etiology and failed medical and endo-
scopic treatment modalities between the periods of 1995 and 2003.
PATIENTS ANDMETHODS: 20 patients who had failed medical
and endoscopic treatment modalities in the Department of Gastro-
enterology had an emergency devascularization procedure in
the Department of Gastrointestinal Surgery of Tu¨rkiye Yu¨ksek
Y´htisas Hospital. These patients were evaluated according to their
demographic properties, etiology, Child score, blood transfusion,
preoperative hospitalization period, morbidity, mortality and
postoperative follow-up. RESULTS: In this series the median age of
the 18 male and 2 female patients was 52 years. The causes of portal
hypertension were hepatitis B in eight patients, hepatitis C in five
patients, cryptogenic cirrhosis in three patients, non-cirrhotic portal
fibrosis in two patients, portal vein thrombosis in one patient. Two
patients were in Child A, 6 patients were in Child B, and 12 patients
were in Child C group. Early postoperative mortality was seen in 9
patients (45%). Median preoperative waiting time was 3 (2–4) days
and preoperative blood transfusions were 13 (12–28) units in the
group who died. Median follow-up was 38 (12–74) months and
neither re-bleeding nor encephalopathy were seen after surgical
management in the early postoperative period. CONCLUSION:
Surgical procedure has to be applied in the treatment of acute variceal
bleeding with correct endication without losing time. Although the
mortality rate is high in poor hepatic function, it is a life-saving
procedure and gives a patient a chance of liver transplantation.
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